Globus Medical Inc
General ticker "GMED" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $11.3B
Globus Medical Inc follows the US Stock Market performance with the rate: 61.6%.
Estimated limits based on current volatility of 1.2%: low 81.79$, high 83.78$
Factors to consider:
- US accounted for 81.6% of revenue in the fiscal year ended 2023-12-31
- Current price 14.3% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [51.43$, 72.72$]
- 2024-12-30 to 2025-12-30 estimated range: [54.59$, 77.13$]
Financial Metrics affecting the GMED estimates:
- Positive: Non-GAAP EPS, $ of 2.33 > 2.29
- Negative: Operating cash flow per share per price, % of 4.45 <= 7.18
- Positive: 1.03 < Operating profit margin, % of 8.49
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: Inventory ratio change, % of 12.81 > 1.08
Short-term GMED quotes
Long-term GMED plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $958.10MM | $1,022.84MM | $1,568.48MM |
| Operating Expenses | $786.15MM | $794.89MM | $1,435.33MM |
| Operating Income | $171.95MM | $227.95MM | $133.14MM |
| Non-Operating Income | $8.45MM | $15.07MM | $32.25MM |
| Interest Expense | $9.30MM | $14.23MM | $0.00MM |
| R&D Expense | $97.35MM | $73.02MM | $124.01MM |
| Income(Loss) | $180.41MM | $243.02MM | $165.39MM |
| Taxes | $31.22MM | $52.85MM | $42.52MM |
| Profit(Loss) | $149.19MM | $190.17MM | $122.87MM |
| Stockholders Equity | $1,741.39MM | $1,846.37MM | $3,997.96MM |
| Inventory | $237.00MM | $298.98MM | $848.13MM |
| Assets | $1,957.26MM | $2,076.13MM | $5,086.08MM |
| Operating Cash Flow | $276.27MM | $178.47MM | $243.50MM |
| Capital expenditure | $56.90MM | $74.05MM | $78.27MM |
| Investing Cash Flow | $-375.94MM | $-110.36MM | $302.97MM |
| Financing Cash Flow | $54.15MM | $-109.96MM | $-231.82MM |
| Earnings Per Share* | $1.48 | $1.89 | $1.09 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.